Study of Cryotherapy for Renal Tumors

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00858975
First received: March 9, 2009
Last updated: August 12, 2013
Last verified: December 2012
  Purpose

The purpose of this study is to study the change of tumor size and serum cytokine in the patients who received cryotherapy for the renal tumors.


Condition Intervention
Renal Tumors
Procedure: cryotherapy

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Study of Cryotherapy for Renal Tumors

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • Tumor size [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 0
Study Start Date: October 2007
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Cryotherapy
The patients who receive cryotherapy for their renal tumors
Procedure: cryotherapy
Placing 4-6 cryotherapy probes into the renal tumors and conducting two cycles of freezing and thawing

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patients who have renal tumor less than 7 cm and receive cryotherapy

Exclusion Criteria:

  • The tumor size is larger than 7 cm
  • The patients do not approve the surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00858975

Locations
Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 100
Sponsors and Collaborators
National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: Yeong-Shiau Pu, Department of Urology / National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00858975     History of Changes
Other Study ID Numbers: 200709063R
Study First Received: March 9, 2009
Last Updated: August 12, 2013
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
renal tumor
cryotherapy
cytokine

Additional relevant MeSH terms:
Kidney Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on July 29, 2014